atenolol has been researched along with t 1583 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurosawa, H; Satoh, E; Taira, N; Yanagisawa, T | 1 |
| Negita, S; Tsuru, H | 1 |
2 other study(ies) available for atenolol and t 1583
| Article | Year |
|---|---|
Selective beta 1-receptor full agonists, T-0509 and T-1583, increase the force monophasically and cyclic AMP biphasically in canine ventricular muscle.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Animals; Atenolol; Carbachol; Catecholamines; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Ethanolamines; Female; In Vitro Techniques; Male; Myocardial Contraction; Papillary Muscles; Propanolamines; Stimulation, Chemical | 1990 |
Heterogeneity of beta-adrenoceptor in canine veins: comparison among the facial, portal and saphenous veins.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bucladesine; Catecholamines; Colforsin; Dogs; Ethanolamines; Face; Isoproterenol; Male; Portal Vein; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Saphenous Vein; Veins | 1989 |